Newsletter | 01 February 2002 Access News 6, Focus on Malaria, February 2002 HIV/AIDS INTELLECTUAL PROPERTY AND TRADE MALARIA TROPICAL & NEGLECTED DISEASES VACCINES How much for an effective malaria treatment is the focus of this edition, as well as MSF in Burundi, Doha and a potential breakthrough, trapped in the ACCESS crisis, life with chagas and HIV and meningitis outbreaks. Read, watch, share Filter by - Any -BlogEventsFeature storyInterviewIssue briefLetterNewsletterOpinion articlePhoto storyPress releaseReportReport seriesResearch articleSpeechStatementTechnical briefVideo Photo credit: Jan-Joseph Stok Letter Letter | 17 August 2023 HIV/AIDS Open letter to ViiV to improve access to HIV prevention drug CAB-LA 1 min Letter Letter | 13 July 2023 HIV/AIDS Intellectual property and trade Colombia CSO letter supporting Resolution 881/23 by Colombia on issuing a compulsory license for HIV drug dolutegravir Photo credit: Paul Odongo/MSF Press release Press release | 11 May 2023 Diagnostics HIV/AIDS Access to point-of-care tests for people with advanced HIV under threat as diagnostics corporations to stop production 3 min Photograph by Valerie Baeriswyl Press release Press release | 30 March 2023 HIV/AIDS Pharmaceutical corporation ViiV must improve its failing access strategy for lifesaving HIV prevention drug 5 min Technical brief | 02 February 2023 HIV/AIDS Agents of Change: Long-acting Formulations for Prevention and Treatment of HIV Photograph by Albert Masias Press release Press release | 29 November 2022 HIV/AIDS Pharmaceutical corporation ViiV must make ground-breaking HIV prevention injection affordable and available 5 min Technical brief | 13 September 2022 Diagnostics Africa-South Korea Roundtable: Working Together on Local Production of Diagnostics Statement | 23 August 2022 Diagnostics Principles for Access to Multi-disease Molecular Diagnostics Load More
Photo credit: Jan-Joseph Stok Letter Letter | 17 August 2023 HIV/AIDS Open letter to ViiV to improve access to HIV prevention drug CAB-LA 1 min
Letter Letter | 13 July 2023 HIV/AIDS Intellectual property and trade Colombia CSO letter supporting Resolution 881/23 by Colombia on issuing a compulsory license for HIV drug dolutegravir
Photo credit: Paul Odongo/MSF Press release Press release | 11 May 2023 Diagnostics HIV/AIDS Access to point-of-care tests for people with advanced HIV under threat as diagnostics corporations to stop production 3 min
Photograph by Valerie Baeriswyl Press release Press release | 30 March 2023 HIV/AIDS Pharmaceutical corporation ViiV must improve its failing access strategy for lifesaving HIV prevention drug 5 min
Technical brief | 02 February 2023 HIV/AIDS Agents of Change: Long-acting Formulations for Prevention and Treatment of HIV
Photograph by Albert Masias Press release Press release | 29 November 2022 HIV/AIDS Pharmaceutical corporation ViiV must make ground-breaking HIV prevention injection affordable and available 5 min
Technical brief | 13 September 2022 Diagnostics Africa-South Korea Roundtable: Working Together on Local Production of Diagnostics
